Imperial Valley News Center
Clearing habitat surrounding farm fields fails to reduce pathogens
- Details
- Written by Sarah Yang
Berkeley, California - The effort to improve food safety by clearing wild vegetation surrounding crops is not helping, and in some cases may even backfire, according to a new study led by researchers at UC Berkeley.
Corrected Protein Structure Reveals Drug Targets for Cancer, Neurodegenerative Diseases
- Details
- Written by Heather Buschman, PhD
San Diego, California - Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death. When it goes awry, a number of diseases may result. In a study published August 13 in Cell Reports, researchers at University of California, San Diego School of Medicine reveal a more accurate structure of PKC, providing new targets for fine-tuning the enzyme’s activity as needed to improve human health.
Astronomers Analyze the Atmosphere of a ‘Young Jupiter’ Exoplanet
- Details
- Written by Susan Brown
San Diego, California - Astronomers have found thousands of planets outside our solar system. Almost all of these exoplanets were detected by measuring periodic changes in the light from their stars.
Timing Devices
- Details
- Written by Peter Dizikes
Cambridge, Massachusetts - Ask enough scholars to explain their work, and sometimes surprising descriptions will emerge.
Researchers pioneer use of capsules to save materials, streamline chemical reactions
- Details
- Written by Jonathan Mingle
Cambridge, Massachusetts - Chemists working in a variety of industries and fields typically go through a laborious process to measure and mix reagents for each reaction they perform. And many of the common reagents they use sit for months or years on shelves in laboratories, where they can react with oxygen and water in the atmosphere, rendering them useless.
Toward smarter selection of therapy for psychiatric disorders
- Details
- Written by Elizabeth Dougherty
Cambridge, Massachusetts - For patients with social anxiety disorder (SAD), current behavioral and pharmaceutical treatments work about half the time. After weeks of investment in therapy, about half of patients will likely still suffer with symptoms of anxiety, and have little choice but to try again with something else. This trial-and-error process - inevitable due to an absence of tools to guide treatment selection - is time-consuming and expensive, and some patients eventually just give up.
Page 2993 of 3785